Acorda Therapeutics, Inc. Gross Margin 2010-2023 | ACOR

Current and historical gross margin for Acorda Therapeutics, Inc. (ACOR) over the last 10 years. The current gross profit margin for Acorda Therapeutics, Inc. as of September 30, 2023 is %.
Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2023-09-30 $0.11B $0.10B 87.39%
2023-06-30 $0.12B $0.10B 82.05%
2023-03-31 $0.12B $0.09B 77.12%
2022-12-31 $0.12B $0.09B 74.79%
2022-09-30 $0.13B $0.10B 76.00%
2022-06-30 $0.12B $0.09B 73.77%
2022-03-31 $0.12B $0.09B 71.54%
2021-12-31 $0.13B $0.09B 68.22%
2021-09-30 $0.13B $0.08B 63.08%
2021-06-30 $0.15B $0.11B 69.08%
2021-03-31 $0.15B $0.11B 72.73%
2020-12-31 $0.15B $0.12B 77.78%
2020-09-30 $0.17B $0.13B 81.21%
2020-06-30 $0.16B $0.13B 83.13%
2020-03-31 $0.18B $0.15B 83.52%
2019-12-31 $0.19B $0.16B 82.29%
2019-09-30 $0.21B $0.16B 77.73%
2019-06-30 $0.31B $0.24B 79.08%
2019-03-31 $0.41B $0.32B 79.22%
2018-12-31 $0.47B $0.38B 79.62%
2018-09-30 $0.59B $0.49B 82.88%
2018-06-30 $0.59B $0.48B 81.97%
2018-03-31 $0.57B $0.47B 81.71%
2017-12-31 $0.59B $0.48B 81.26%
2017-09-30 $0.54B $0.43B 78.70%
2017-06-30 $0.54B $0.42B 78.88%
2017-03-31 $0.52B $0.41B 78.97%
2016-12-31 $0.52B $0.41B 79.23%
2016-09-30 $0.51B $0.41B 79.61%
2016-06-30 $0.52B $0.42B 80.65%
2016-03-31 $0.51B $0.41B 80.75%
2015-12-31 $0.49B $0.40B 80.93%
2015-09-30 $0.48B $0.39B 80.83%
2015-06-30 $0.44B $0.35B 79.91%
2015-03-31 $0.42B $0.34B 80.05%
2014-12-31 $0.40B $0.32B 79.85%
2014-09-30 $0.38B $0.30B 80.11%
2014-06-30 $0.36B $0.29B 80.06%
2014-03-31 $0.35B $0.28B 80.06%
2013-12-31 $0.34B $0.27B 80.12%
2013-09-30 $0.33B $0.26B 80.31%
2013-06-30 $0.32B $0.26B 80.76%
2013-03-31 $0.31B $0.25B 81.05%
2012-12-31 $0.31B $0.25B 81.64%
2012-09-30 $0.30B $0.24B 81.82%
2012-06-30 $0.31B $0.24B 77.96%
2012-03-31 $0.30B $0.24B 77.81%
2011-12-31 $0.29B $0.23B 77.05%
2011-09-30 $0.29B $0.22B 76.57%
2011-06-30 $0.26B $0.21B 80.54%
2011-03-31 $0.24B $0.19B 80.43%
2010-12-31 $0.19B $0.16B 80.73%
2010-09-30 $0.14B $0.11B 81.29%
2010-06-30 $0.09B $0.07B 82.22%
2010-03-31 $0.06B $0.05B 81.67%
2009-12-31 $0.05B $0.04B 81.48%